-
AI-based Medical Device Company Imidex and Orbit Genomics Form Strategic Relationship to Explore the Detection of Lung Cancer in Early Stages
https://www.prnewswire.com/news-releases/ai-based-medical-device-company-imidex-and-precision-genomix-company-orbit-genomics-form-strategic-relationship-to-explore-the-detection-of-lung-cancer-in-early-stages-302229700.html?tc=eml_cleartime
-
Orbit Genomics Celebrates Graduation From The Cancer X Accelerator Program
Orbit Genomics is proud to attend the graduation of the CancerX Accelerator’s inaugural cohort. We were selected from over 100 startup applicants to participate in this year’s program which included months of mentorship, hands-on learning at the Moffit Cancer Center, and many professional sessions with Champions. We look forward to continue strengthening the relationships with
-
Orbit Genomics Has Been Selected For The Inaugural Cohort of Startups In CancerX’s Accelerator Program
We are thrilled to announce that Orbit Genomics has been selected for the inaugural cohort of startups in CancerX’s Accelerator program! CancerX is a public-private partnership announced by The White House as a national accelerator to boost innovation in the fight against cancer as part of the reignited Cancer Moonshot. A team of Accelerator Champions
